These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30918270)

  • 1. Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies.
    Hussain A; AlAjmi MF; Rehman MT; Amir S; Husain FM; Alsalme A; Siddiqui MA; AlKhedhairy AA; Khan RA
    Sci Rep; 2019 Mar; 9(1):5237. PubMed ID: 30918270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Spectral Characterization, DNA/ Protein Binding, DNA Cleavage, Cytotoxicity, Antioxidative and Molecular Docking Studies of Cu(II)Complexes Containing Schiff Base-bpy/Phen Ligands.
    Anupama B; Aruna A; Manga V; Sivan S; Sagar MV; Chandrashekar R
    J Fluoresc; 2017 May; 27(3):953-965. PubMed ID: 28097460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Example of two novel thiocyanato bridged copper (II) complexes derived from substituted thiosemicarbazone ligand: structural elucidation, DNA/albumin binding, biological profile analysis, and molecular docking study.
    Biswas N; Saha S; Khanra S; Sarkar A; Prasad Mandal D; Bhattacharjee S; Chaudhuri A; Chakraborty S; Roy Choudhury C
    J Biomol Struct Dyn; 2019 Jul; 37(11):2801-2822. PubMed ID: 30101692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ni(ii)/Cu(ii)/Zn(ii) 5,5-diethylbarbiturate complexes with 1,10-phenanthroline and 2,2'-dipyridylamine: synthesis, structures, DNA/BSA binding, nuclease activity, molecular docking, cellular uptake, cytotoxicity and the mode of cell death.
    Yilmaz VT; Icsel C; Suyunova F; Aygun M; Aztopal N; Ulukaya E
    Dalton Trans; 2016 Jun; 45(25):10466-79. PubMed ID: 27263797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
    Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
    J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of DNA/Protein interactions and cytotoxic studies of copper(II) complexes incorporated with N, N donor ligands and terpyridine ligand.
    Tummalapalli K; C S V; Munusami P; Pathak M; M M B
    Int J Biol Macromol; 2017 Feb; 95():1254-1266. PubMed ID: 27838416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in silico study of the biological activity of tetradentate Schiff base copper(II) complexes with ethylenediamine-bridge.
    Mijatović A; Gligorijević N; Ćoćić D; Spasić S; Lolić A; Aranđelović S; Nikolić M; Baošić R
    J Inorg Biochem; 2023 Jul; 244():112224. PubMed ID: 37080139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, DNA/proteins binding, docking and cytotoxicity studies of copper(II) complexes with the first quinolone drug nalidixic acid and 2,2'‑dipyridylamine.
    Kumar M; Kumar G; Mogha NK; Jain R; Hussain F; Masram DT
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Apr; 212():94-104. PubMed ID: 30616168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental and molecular modelling demonstration of effective DNA and protein binding as well as anticancer potential of two mononuclear Cu(II) and Co(II) complexes with isothiocyanate and azide as anionic residues.
    Satapathi D; Das M; Das UK; Laha S; Kundu P; Choudhuri I; Bhattacharya N; Samanta BC; Chattopadhyay N; Maity T
    Int J Biol Macromol; 2024 Aug; 275(Pt 2):133716. PubMed ID: 38977049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity.
    Jaividhya P; Ganeshpandian M; Dhivya R; Akbarsha MA; Palaniandavar M
    Dalton Trans; 2015 Jul; 44(26):11997-2010. PubMed ID: 26076117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand.
    Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M
    Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a Synthesized Amyl-Glycine1, 10-Phenanthroline Platinum Nitrate on Structure and Stability of Human Blood Carrier Protein, Albumin: Spectroscopic and Modeling Approaches.
    Shafaei Z; Abazari O; Divsalar A; Ghalandari B; Poursoleiman A; Saboury AA; Ahmad F
    J Fluoresc; 2017 Sep; 27(5):1829-1838. PubMed ID: 28555407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: the role of co-ligand planarity on DNA binding and cleavage and anticancer activity.
    Jaividhya P; Dhivya R; Akbarsha MA; Palaniandavar M
    J Inorg Biochem; 2012 Sep; 114():94-105. PubMed ID: 22841366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activity.
    Qin XY; Liu YN; Yu QQ; Yang LC; Liu Y; Zhou YH; Liu J
    ChemMedChem; 2014 Aug; 9(8):1665-71. PubMed ID: 24839939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albumin.
    Gou Y; Zhang Y; Qi J; Zhou Z; Yang F; Liang H
    J Inorg Biochem; 2015 Mar; 144():47-55. PubMed ID: 25573806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(II) complexes with non-steroidal anti-inflammatory drugs: Structural characterization, in vitro and in silico biological profile.
    Malis G; Geromichalou E; Geromichalos GD; Hatzidimitriou AG; Psomas G
    J Inorg Biochem; 2021 Nov; 224():111563. PubMed ID: 34399232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of copper(II) complexes with Schiff bases derived from N'-tosylbenzene-1,2-diamine.
    Diz M; Durán-Carril ML; Castro J; Alvo S; Bada L; Viña D; García-Vázquez JA
    J Inorg Biochem; 2022 Nov; 236():111975. PubMed ID: 36055108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, structure information, DNA/BSA binding affinity and in vitro cytotoxic studies of mixed ligand copper(II) complexes containing a phenylalanine derivative and diimine co-ligands.
    Annaraj B; Balakrishnan C; Neelakantan MA
    J Photochem Photobiol B; 2016 Jul; 160():278-91. PubMed ID: 27155593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, X-ray crystal structure, DNA/BSA binding, DNA cleavage and cytotoxicity studies of phenanthroline based copper(II)/zinc(II) complexes.
    Wang Q; Mao H; Wang W; Zhu H; Dai L; Chen Y; Tang X
    Biometals; 2017 Aug; 30(4):575-587. PubMed ID: 28616784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.